| |
 |
|
Class Information
Number: 424/9.1
Name: Drug, bio-affecting and body treating compositions > In vivo diagnosis or in vivo testing
Description: Subject matter which includes compositions intended for use in in vivo testing or in vivo diagnosis and nominal methods of using compounds or compositions for in vivo testing or in vivo diagnosis.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 424/9.6 |
Diagnostic or test agent produces in vivo fluorescence |
316 |
| 424/9.7 |
Diagnostic or test agent produces visible change in mouth |
28 |
| 424/9.8 |
Diagnostic or test agent produces visible change on skin |
43 |
| 424/9.3 |
Magnetic imaging agent (e.g., nmr, mri, mrs, etc.) |
395 |
| 424/9.2 |
Testing efficacy or toxicity of a compound or composition (e.g., drug, vaccine, etc.) |
709 |
| 424/9.5 |
Ultrasound contrast agent |
187 |
| 424/9.4 |
X-ray contrast imaging agent (e.g., computed tomography, angiography, etc.) |
324 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7618793 |
Identifying agents for decreasing cellular toxicity associated with huntingin polypeptide |
Nov. 17, 2009 |
| 7618615 |
Methods for providing neuroprotection for the animal central nervous system against neurodegeneration caused by ischemia |
Nov. 17, 2009 |
| 7618614 |
Hydrocephalus treatment |
Nov. 17, 2009 |
| 7615222 |
Enriched antibody for detecting mycobacterial infection, methods of use and diagnostic test employing same |
Nov. 10, 2009 |
| 7615208 |
Metal ion-labeled bis-aminoethanethiol-targeting ligand conjugates, compositions, and methods for tissue-specific disease imaging |
Nov. 10, 2009 |
| 7615207 |
Methods for treating irritable bowel syndrome |
Nov. 10, 2009 |
| 7611720 |
Tuberculosis vaccines including recombinant BCG strains expressing alanine dehydrogenase, serine dehydratase and/or glutamine synthetase |
Nov. 3, 2009 |
| 7611693 |
Mechanism-based targeted pancreatic beta cell imaging and therapy |
Nov. 3, 2009 |
| 7611692 |
Gastrin releasing peptide compounds |
Nov. 3, 2009 |
| 7610074 |
Multi-functional plasmon-resonant contrast agents for optical coherence tomography |
Oct. 27, 2009 |
| 7608406 |
Diagnostic markers of stroke and cerebral injury and methods of use thereof |
Oct. 27, 2009 |
| 7608278 |
Formulations of hydrophobic proteins in an immunogenic composition having improved tolerability |
Oct. 27, 2009 |
| 7608277 |
Tuberculosis nucleic acids, polypeptides and immunogenic compositions |
Oct. 27, 2009 |
| 7608247 |
Use of outer membrane protein a in treatment/prevention/diagnosis of bacterial infection in central nervous system and/or peripheral blood circulation |
Oct. 27, 2009 |
| 7608246 |
Apolipoprotein E as an adjuvant for lipid antigens |
Oct. 27, 2009 |
| 7608245 |
Methods for manipulating satiety |
Oct. 27, 2009 |
| 7608244 |
Hydrophilic light absorbing compositions for determination of physiological function in critically ill patients |
Oct. 27, 2009 |
| 7605248 |
Recombinant constructs of Borrelia burgdorferi |
Oct. 20, 2009 |
| 7605182 |
Compounds that selectively bind to membranes of apoptotic cells |
Oct. 20, 2009 |
| 7604953 |
Bioamplification for microbial sensor signal transduction |
Oct. 20, 2009 |
| 7601509 |
Biotype diets system: predicting food allergies by blood type |
Oct. 13, 2009 |
| 7601357 |
Targeting of long chain triacylglycerol hydrolase gene for tuberculosis treatment |
Oct. 13, 2009 |
| 7601333 |
Use of a tetrapeptide AcSDKP (SEQ ID No. 1) analog resistant to the angiotensin I converting enzyme for measuring glomerular filtration rate in a human or an animal and kit containing same |
Oct. 13, 2009 |
| 7601332 |
Vitamin receptor binding drug delivery conjugates |
Oct. 13, 2009 |
| 7601331 |
NIR-sensitive nanoparticle |
Oct. 13, 2009 |
| 7598046 |
Use of prion conversion modulating agents |
Oct. 6, 2009 |
| 7598041 |
HIV-1 VPR interactions with mitochondrial apoptosis inducing factor and methods of using the same |
Oct. 6, 2009 |
| 7597896 |
Composition comprising a protein encoded by a modified ERP gene of Mycobacterium |
Oct. 6, 2009 |
| 7597891 |
Synthesis of human secretory IgA for the treatment of Clostridium difficile associated diseases |
Oct. 6, 2009 |
| 7597878 |
Optical fluorescent imaging |
Oct. 6, 2009 |
| 7591997 |
Method for determining the susceptibility of a subject to infection |
Sep. 22, 2009 |
| 7591996 |
Ultrasound target vessel occlusion using microbubbles |
Sep. 22, 2009 |
| 7588887 |
Stable isotope metabolic labeling for analysis of biopolymers |
Sep. 15, 2009 |
| 7588751 |
Liposome-containing radiographic contrast medium and preparation method thereof |
Sep. 15, 2009 |
| 7586020 |
Methods for determining effects of maternal treatments on offspring |
Sep. 8, 2009 |
| 7585492 |
Biomolecular contrast agents for therapy success and dose monitoring in radiation therapy with proton or ion beams |
Sep. 8, 2009 |
| 7582603 |
Method for treating or inhibiting intestinal inflammation |
Sep. 1, 2009 |
| 7582281 |
Ethylenedicysteine (EC)-drug conjugates compositions and methods for tissue specific disease imaging |
Sep. 1, 2009 |
| 7582280 |
Conjugates of antioxidants with metal chelating ligands for use in diagnostic and therapeutic applications |
Sep. 1, 2009 |
| 7579322 |
Compositions and methods for promoting myocardial and peripheral angiogenesis |
Aug. 25, 2009 |
| 7579012 |
Targeting of triacylglycerol synthase gene for tuberculosis treatment |
Aug. 25, 2009 |
| 7579009 |
Whole bacterial cells as immune modulator |
Aug. 25, 2009 |
| 7579005 |
Process for recombinant expression and purification of antimicrobial peptides using periplasmic targeting signals as precipitable hydrophobic tags |
Aug. 25, 2009 |
| 7576181 |
Method of administering porcine B-domainless fVIII |
Aug. 18, 2009 |
| 7575928 |
Genes for diagnosing colorectal cancer |
Aug. 18, 2009 |
| 7575877 |
Method of diagnosing tuberculosis |
Aug. 18, 2009 |
| 7572903 |
Method of regulation of bacterial persister status |
Aug. 11, 2009 |
| 7572457 |
Use of Streptococcus suis 38 kDa polypeptide as an immunogen |
Aug. 11, 2009 |
| 7572446 |
Antagonists of HMG1 for treating inflammatory conditions |
Aug. 11, 2009 |
| 7572434 |
Method for assessing the effect of a drug on long term memory formation |
Aug. 11, 2009 |
|
|
|
